Percutaneous Coronary Intervention After Subcutaneous Enoxaparin Pretreatment in Patients With Unstable Angina Pectoris

A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Unstable Coronary Artery Disease

1997 • 1,447 citations

Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE study

1997 • 1,346 citations

Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study

1999 • 1,296 citations

Enoxaparin Prevents Death and Cardiac Ischemic Events in Unstable Angina/Non–Q-Wave Myocardial Infarction

1999 • 1,077 citations

Hirudin in Acute Myocardial Infarction

1996 • 501 citations

Assessment of the Treatment Effect of Enoxaparin for Unstable Angina/Non–Q-Wave Myocardial Infarction

1999 • 481 citations

Platelet Activation With Unfractionated Heparin at Therapeutic Concentrations and Comparisons With a Low-Molecular-Weight Heparin and With a Direct Thrombin Inhibitor

1998 • 388 citations

Early Increase of von Willebrand Factor Predicts Adverse Outcome in Unstable Coronary Artery Disease

1998 • 258 citations

Low molecular weight heparin in prevention of restenosis after angioplasty. Results of Enoxaparin Restenosis (ERA) Trial.

1994 • 185 citations

Low Molecular Weight Heparin After Mechanical Heart Valve Replacement

2000 • 161 citations

Fish Oils and Low-Molecular-Weight Heparin for the Reduction of Restenosis After Percutaneous Transluminal Coronary Angioplasty

1996 • 160 citations

Dose-Ranging Trial of Enoxaparin for Unstable Angina: Results of TIMI 11A 11A list of the participating investigators and clinical centers for the TIMI 11A trial appears in the Appendix A.

1997 • 155 citations

Effects of various anticoagulant treatments on von Willebrand factor release in unstable angina

2000 • 130 citations

Low molecular weight heparin (reviparin) in percutaneous transluminal coronary angioplasty results of a randomized, double-blind, unfractionated heparin and placebo-controlled, multicenter trial (REDUCE trial)

1996 • 124 citations

Usefulness of intravenous enoxaparin for percutaneous coronary intervention in stable angina pectoris

1999 • 93 citations

Increased platelet responsiveness following coronary stenting Heparin as a possible aetiological factor in stent thrombosis

1998 • 50 citations

Early angiography versus conservative treatment in patients with non–ST elevation acute myocardial infarction

2000 • 48 citations

Effect of Nadroparin, a Low-Molecular-Weight Heparin, on Clinical and Angiographic Restenosis After Coronary Balloon Angioplasty

1997 • 48 citations

Combination enoxaparin and abciximab therapy during percutaneous coronary intervention: "NICE guys finish first".

2000 • 44 citations

Low molecular weight heparins in the cardiac catheterization laboratory.

1999 • 18 citations

Platelet glycoprotein IIb/IIIa receptor blockers: An appropriate-use model for expediting care in acute coronary syndromes

2000 • 11 citations